FindTrial
Sign In

Influence of the positioning of the electrodes on the pain relief provided by TENS

Positioning of electrodes influence on hyporalgesia induced by TENS

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9gnpdp
Enrollment
Unknown
Registered
2018-02-05
Start date
2017-11-26
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unspecified pain

Interventions

The subjects will be randomized into 6 groups (n = 25 per group) described below: Group 1 - Stimulation in dermatome + active TENS: all allocated subject will receive treatment with active TENS in dom
Device
E02.331

Sponsors

Fundação Universidade Federal de Sergipe
Lead Sponsor
Laboratório de Pesquisa em Neurociência (LAPENE) - Universidade Federal de Sergipe
Collaborator
Fundação Universidade Federal de Sergipe
Collaborator

Eligibility

Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Healthy subjects; Age 18-45 years old; Agree to participate in the study

Exclusion criteria

Exclusion criteria: Pain; loss or damage to the nerves of the upper and lower; pregnancy; cardiac pacemaker; allergy to carbon electrodes;use of analgesic medication or psychiatric; changed conditions of the skin or loss of sensitivity in the areas of placement of the electrodes; history of current pain or surgery in the application region of TENS.

Design outcomes

Primary

MeasureTime frame
Increased pain threshold by individuals pressure when stimulated by the active TENS especially when applied in a region of dermatomes. For the evaluation, the pressure algometer will be used. And for verification the expected outcome, a variation of at least 5% in scales and test used pre and post intervention will be considered.—

Secondary

MeasureTime frame
Reduction of perceived pain, to measure this variable will be used the algometry test and numeric scale of pain. To verify the expected outcomes, a variation of at least 5% in each scale and test used before and after treatment will be considered.;Increased conditioned pain modulation effect. To measure these variables will be used algometry tests. To verify the expected outcomes, a variation of at least 5% in each scale and test used before and after treatment will be considered.;Reduction of the phenomenon of temporal summation, for the measurement of these variables will be used the algometry and numeric scale of the pain tests. To verify the expected outcomes, a variation of at least 5% in each scale and test used before and after treatment will be considered.—

Countries

Brazil

Contacts

Public ContactMayara Agripino

Universidade Federal de Sergipe

mayara_ellen@hotmail.com+5579988335320

Outcome results

None listed

Source: REBEC (via WHO ICTRP)